Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading vertically integrated cannabis operator in the United States, announced today that it will expand its award-winning line of Select Oil brand products to service the medical patients of Ohio with 11 million residence and currently 131,654 medical cardholders, starting with its best-selling Select Elite cannabis oil cartridges.
Select, America’s #1 Cannabis Oil Brand, was acquired by Curaleaf in February 2020 and can be found in 14 states including Arizona, California, Colorado, Connecticut, Florida, Maryland, Michigan, Nevada, New York, Ohio, Oklahoma, Oregon, Massachusetts, and Maine. As a recognized industry leader, Select is committed to meeting high quality control standards and testing transparency and delivering a smooth, flavorful experience.
Select products will be available at dispensaries statewide starting with our Select Elite cartridges, the brand’s best-selling product, which deliver activated broad-spectrum oil with smooth vapor. The brand looks forward to unveiling more of its leading product offerings in Ohio soon, including its multi-purpose, fast-acting CBD:THC Ratio Drops which are slated to launch on October 19th. Select Ratio Drops come in four varieties – 1:1, 18:1, 4:1 and THC – allowing for a controlled and customized cannabis experience.
“We have grown to become the largest cannabis operator in the U.S. by listening to the needs of our patients and customers and delivering products that fundamentally change lives for the better,” says Joe Bayern, President at Curaleaf. “We are excited to extend this commitment to Ohio by offering them Select products, which are known to undergo the most stringent and progressive oil testing in the industry.”
Currently, there are 52 licensed medical marijuana dispensaries operating in Ohio. According to the August 2020 patient & caregiver report published by The State of Ohio Board of Pharmacy, there are 131,654 registered patients with the state and 14,775 registered caregivers; making up 131,654 licensed physicians from the state who may recommend medical cannabis for the treatment of one of 21 qualifying medical conditions listed under Ohio law. For more information about Ohio’s Medical Marijuana Control Program, visit www.medicalmarijuana.ohio.gov.
About Curaleaf Holdings, Inc.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is the leading vertically integrated U.S. multi-state cannabis operator with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. Curaleaf currently operates in 23 states with 93 dispensaries, 22 cultivation sites and over 30 processing sites, and employs over 3,000 team members across the United States. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information please visit www.curaleaf.com.